The Acetazolamide Challenge: Techniques and Applications in the Evaluation of Chronic Cerebral Ischemia

References

1. ↵
   Kuroda, S, Kamiyama H, Abe H, et al. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery 1993;32:912–19

   CrossRefPubMedWeb of Science
2. ↵
   Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110–16

   Abstract/FREE Full Text
3. ↵
   Kleiser B, Widder B. Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke 1992;23:171–74

   Abstract/FREE Full Text
4. ↵
   Vernieri F, Pasqualetti P, Passarelli F, et al. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999;30:593–98

   Abstract/FREE Full Text
5. ↵
   Ogasawara K, Ogawa A, Terasaki K. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002;22:1142–48

   CrossRefPubMed
6. ↵
   Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251–59

   Abstract/FREE Full Text
7. ↵
   Derdeyn CP. Cerebral hemodynamics in carotid occlusive disease. AJNR Am J Neuroradiol 2003;24:1497–99

   FREE Full Text
8. ↵
   Derdeyn CP, Grubb RL Jr, Powers WJ. Hemodynamic and metabolic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998;19:1463–69

   Abstract
9. ↵
   Derdeyn CP, Videen TO, Yundt KD, et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral hemodynamic impairment revisited. Brain 2002;125:595–607

   Abstract/FREE Full Text
10. ↵
    Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991;29:231–40

    CrossRefPubMedWeb of Science
11. ↵
    Powers WJ, Press GA, Grubb RL, et al. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med 1987;106:27–34

    CrossRefPubMedWeb of Science
12. ↵
    Dirnagl U, Pulsinelli W. Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 1990;10:327–36

    PubMedWeb of Science
13. ↵
    Kety SS, King BD, Horvath SM, et al. The effects of an acute reduction in blood pressure by means of differential spinal sympathetic block on the cerebral circulation of hypertensive patients. J Clin Invest 1950;29:402–07

    CrossRefPubMedWeb of Science
14. ↵
    Baron JC, Bousser MG, Rey A, et al. Reversal of focal “misery perfusion syndrome” by extra-intracranial bypass in hemodynamic cerebral ischemia: a case study with 0–15 positron emission tomography. Stroke 1981;12:454–59

    Abstract/FREE Full Text
15. ↵
    Schumann P, Touzani O, Young AR, et al. Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain 1998;121:1369–79

    Abstract/FREE Full Text
16. ↵
    McHenry LC Jr, Fazekas JF, Sullivan JF. Cerebral hemodynamics of syncope. Am J Med Sci 1961;80:173–78
17. ↵
    Grubb RL Jr, Raichle ME, Phelps ME, et al. Effects of increased intracranial pressure on cerebral blood volume, blood flow, and oxygen utilization in monkeys. J Neurosurg 1975;43:385–98

    CrossRefPubMedWeb of Science
18. ↵
    Baron JC. Perfusion thresholds in human ischemia: historical perspective and therapeutic applications. Cerebrovasc Dis 2001;11:2–8

    CrossRefPubMedWeb of Science
19. ↵
    Rogg J, Rutigliano M, Yonas H, et al. The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve. AJR American J Roentegenol 1989;53:605–12
20. ↵
    Yonas H, Pindzola RR. Physiological determination of cerebrovascular reserves and its use in clinical management. Cerebrovasc Brain Metab Rev 1994;6:325–40

    PubMedWeb of Science
21. ↵
    Vorstrup S, Brun B, Lassen NA. Evaluation of cerebral vasodilatory capacity by acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986;17:1291–98

    Abstract/FREE Full Text
22. ↵
    Lassen NA, Palvolgyi R. Cerebral steal during hypercapnia and the inverse reaction during hypocapnia observed with the 133 xenon technique in man. Scand J Chin Lab Invest Suppl1968;102:XIII :D
23. ↵
    Sullivan HG, Kingsbury TB, Morgan ME, et al. The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 1987;67:525–34

    PubMedWeb of Science
24. ↵
    Burt RW, Witt RM, Cikrit DF, et al. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 1992;182:461–66

    PubMedWeb of Science
25. ↵
    Komiyama M, Nishikawa M, Yasui T, et al. Reversible pontine ischemia caused by acetazolamide challenge. AJNR Am J Neuroradiol 1997;18:1782–84

    Abstract
26. ↵
    Piepgras A, Schmiedek P, Leinsinger G, et al. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke 1990;21:1306–11

    Abstract/FREE Full Text
27. ↵
    Epocrates online. Available at: http://www.rxlist.com/acetazolamide-injection-drug.htm. Accessed December 29,2008
28. ↵
    Yonas H, Darby JM, Marks EC, et al. CBF measured by xe-CT: approach to analysis and normal values. J Cereb Blood Flow Metab 1991;11:716–25

    CrossRefPubMed
29. ↵
    Eskey CJ, Sanelli PC. Perfusion imaging of cerebrovascular reserve. Neuroimag Clin N Am 2005;15:367–81

    CrossRef
30. ↵
    Yonas H, Pindzola RR, Meltzer CC, et al. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998;42:1005–12

    CrossRefPubMedWeb of Science
31. ↵
    Latchaw RE, Yonas H, Pentheny SL, et al. Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology 1987;163:251–54

    CrossRefPubMedWeb of Science
32. ↵
    Chen A, Shyr M-H, Chen T-Y, et al. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol 2006;27:1876–81

    Abstract/FREE Full Text
33. ↵
    Rim NJ, Kim HS, Shin YS, et al. Which CT perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients. AJNR Am J Neuroradiol 2008;29:1658–63

    Abstract/FREE Full Text
34. ↵
    Eastwood JD, Alexander MJ, Petrella JR, et al. Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. AJNR Am J Neuroradiol 2002;23:285–87

    Abstract/FREE Full Text
35. ↵
    Furukawa M, Kashiwagi S, Matsunaga N, et al. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr 2002;26:272–78

    CrossRefPubMedWeb of Science
36. ↵
    Gillard JH, Minhas PS, Hayball MP, et al. Assessment of quantitative computed tomographic cerebral perfusion imaging with H215O positron emission tomography. Neurol Res 2000;22:457–64

    PubMedWeb of Science
37. ↵
    Bisdas S, Nemetiz O, Berding G, et al. Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease. Eur Radiol 2006;16:2220–28

    CrossRefPubMed
38. ↵
    Kudo K, Terae S, Katoh C, et al. Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. AJNR Am J Neuroradiol 2003;24:419–26

    Abstract/FREE Full Text
39. ↵
    Kealey SM, Loving VA, Delong DM, et al. User-defined vascular input function curves: influence on mean perfusion parameter values and signal-to-noise ratio. Radiology 2004;231:587–93

    PubMed
40. ↵
    Sanelli PC, Nicola G, Tsiouris AJ, et al. Reproducibility of postprocessing of quantitative CT perfusion maps. AJR Am J Roentgenol 2007;188:213–18

    CrossRefPubMed
41. ↵
    Waaijer A,Van der Schaaf IC,Velthuis BK, et al. Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis. AJNR Am J Neuroradiol 2007;28:927–32

    Abstract/FREE Full Text
42. ↵
    Navabi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999;213:141–49

    CrossRefPubMedWeb of Science
43. ↵
    Kamath A, Smith WS, Powers WJ, et al. Perfusion CT compared to H(2) (15)O/O (15)O PET in patients with chronic cervical carotid artery occlusion. Neuroradiology 2008;50:745–51. Epub 2008 May 29

    CrossRefPubMed
44. ↵
    Sakamoto S, Ohba S, Shibukawa M, et al. CT perfusion imaging for childhood Moyamoya disease before and after surgical revascularization. Acta Neurochir (Wien) 2006;148:77–81. Epub 2005 Sep 26

    CrossRefPubMed
45. ↵
    Lin W, Celik A, Derdeyn C, et al. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging 2001;14:659–67

    CrossRefPubMed
46. ↵
    Mukherjee P, Kang HC, Videen TO, et al. Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. AJNR Am J Neuroradiol 2003;24:862–71

    Abstract/FREE Full Text
47. ↵
    Berthezene Y, Nighoghossian N, Meyer R, et al. Can cerebrovascular reactivity be assessed by dynamic susceptibility contrast-enhanced MRI? Neuroradiology 1998;40:1–5

    CrossRefPubMedWeb of Science
48. Guckel FJ, Brix G, Schmiedek P, et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 1996;201:405–12

    CrossRefPubMed
49. Schreiber WG, Guckel F, Stritzke P, et al. Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998;18:1143–56

    CrossRefPubMedWeb of Science
50. ↵
    Yen YF, Field AS, Martin EM, et al. Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge. Magn Reson Med 2002;47:921–28

    CrossRefPubMedWeb of Science
51. ↵
    Detre JA, Samuels OB, Alsop DC, et al. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging 1999;10:870–75

    CrossRefPubMedWeb of Science
52. ↵
    Ma J, Mehrkens JH, Holtmannspoetter M, et al. Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT. Neuroradiology 2007;49:317–26. Epub 2007 Jan 3

    CrossRefPubMed
53. ↵
    Grandin CB, Bol A, Smith AM, et al. Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatability and comparison with PET in humans. Neuroimage 2005;26:525–35

    PubMedWeb of Science
54. ↵
    Wirestam R, Andersson L, Ostergaard L, et al. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000;43:691–70

    CrossRefPubMedWeb of Science
55. Rempp KA, Brix G, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41

    CrossRefPubMedWeb of Science
56. ↵
    Vonken EJ, van Osch MJ, Bakker CJ, et al. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109–17

    CrossRefPubMed
57. ↵
    Arbab AS, Aoki S, Toyama K, et al. Quantitative measurement of regional cerebral blood flow with flow-sensitive alternating inversion recovery imaging: comparison with [Iodine 123]-iodoamphetamin single photon emission CT. AJNR Am J Neuroradiol 2002;23:381–88

    Abstract/FREE Full Text
58. ↵
    Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clinical practice. Part 1. Technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34

    Abstract/FREE Full Text
59. ↵
    Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clinical practice. Part 2. Hypoperfusion patterns. AJNR Am J Neuroradiol 2008;29:1235–41

    Abstract/FREE Full Text
60. ↵
    Gibbs JM, Wise RJ, Leenders KI, et al. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984;1:310–14

    CrossRefPubMedWeb of Science
61. ↵
    Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992–98

    Abstract/FREE Full Text
62. ↵
    Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055–60

    CrossRefPubMedWeb of Science
63. ↵
    Kuroda S, Shiga T, Houkin K, et al. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease. Stroke 2006;37:393–98. Epub 2005 Dec 29

    Abstract/FREE Full Text
64. Nemoto EM, Yonas H, Kuwabara H, et al. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 2004;24:1081–89

    PubMed
65. ↵
    Hokari M, Kuroda S, Shiga T, et al. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease. Surg Neurol 2008 May 29. [Epub ahead of print]
66. ↵
    Derdeyn CP, Videen TO, Fritsch SM, et al. Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke 1999;30:1019–24

    Abstract/FREE Full Text
67. ↵
    Powers WJ, Martin WR, Herscovitch P, et al. Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. Neurology 1984;34:168–74
68. ↵
    Ogasawara K, Ito H, Sasoh M, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET. J Nucl Med 2003;44:520–25

    Abstract/FREE Full Text
69. ↵
    Okazawa H, Yamauchi H, Sugimoto K, et al. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease. J Nucl Med 2003;44:1371–78

    Abstract/FREE Full Text
70. ↵
    Hashikawa K, Matsumoto M, Moriwaki H, et al. Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention. J Nucl Med 1994;35:1226–33

    Abstract/FREE Full Text
71. Hattori N, Yonekura Y, Tanaka F, et al. One day protocol for cerebral perfusion reserve with acetazolamide. J Nucl Med 1996;37:2057–61

    Abstract/FREE Full Text
72. ↵
    Sugawara Y, Kikuchi T, Ueda T, et al. Usefulness of brain SPECT to evaluate brain tolerance and hemodynamic changes during temporary balloon occlusion test and after permanent carotid occlusion. J Nucl Med 2002;43:1616–23

    Abstract/FREE Full Text
73. ↵
    Hiroaki H, Takashi O, Seishi J, et al. Cerebral blood flow study in patients with Moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994;35:44–50

    Abstract/FREE Full Text
74. ↵
    Lee HY, Paeng JC, Lee DS, et al. Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT. J Nucl Med 2004;45:202–06

    Abstract/FREE Full Text
75. ↵
    Webster MW, Makaroun MS, Steed DL, et al. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995;21:1–13
76. ↵
    Derdeyn CP, Carpenter DA, Videen TO, et al. Patterns of infarction in hemodynamic failure. Cerebrovasc Dis 2007;24:11–19

    CrossRefPubMed
77. ↵
    Derdeyn CP. Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease. Neuroimaging Clin N Am 2007;17:303–11

    CrossRefPubMedWeb of Science
78. ↵
    Yonas H, Smith HA, Durham SR, et al. Increase stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483–89

    CrossRefPubMedWeb of Science
79. ↵
    Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000;283:2122–27

    CrossRefPubMedWeb of Science
80. ↵
    Schoof J, Lubahn W, Baeumer M, et al. Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007;134:690–96

    CrossRefPubMedWeb of Science
81. ↵
    Suzuki J, Takaku A. Cerebral vascular “Moyamoya disease”: a disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99

    CrossRefPubMedWeb of Science
82. ↵
    Mesiwala AH, Sviri G, Fatemi N, et al. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with Moyamoya disease in the US. Neurosurg Focus 2008;24:E15

    PubMed
83. Imaizumi T, Hayashi K, Saito K, et al. Long-term outcomes of pediatric Moyamoya disease monitored to adulthood. Pediatr Neurol 1998;18:321–25

    CrossRefPubMedWeb of Science
84. Karasawa J, Touho H, Ohnishi H, et al. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood Moyamoya disease. J Neurosurg 1992;77:84–89

    CrossRefPubMedWeb of Science
85. Isono M, Ishii K, Kamida T, et al. Long-term outcomes of pediatric Moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg 2002;36:14–21

    CrossRefPubMed
86. Karasawa J, Kikuchi H, Furuse S, et al. Treatment of Moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978;49:679–88

    PubMedWeb of Science
87. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for Moyamoya disease in children. Neurosurg Clin North Am 2001;12:575–84, ix

    PubMedWeb of Science
88. Srinivasan J, Britz GW, Newell DW. Cerebral revascularization for Moyamoya disease in adults. Neurosurg Clin North Am 2001;12:585–94, ix

    PubMed
89. ↵
    Ishikawa T, Houkin K, Kamiyama H, et al. Effects of surgical revascularization on outcome of patients with pediatric Moyamoya disease. Stroke 1997;28:1170–73

    Abstract/FREE Full Text
90. ↵
    Kuwubara Y, Ichiya Y, Otsuka M, et al. Cerebral hemodynamic change in the child and the adult with Moyamoya disease. Stroke 1990;21:272–77

    Abstract/FREE Full Text
91. ↵
    Ogawa A, Yoshimoto T, Suzuki J, et al. Cerebral blood flow in Moyamoya disease. Part 1. Correlation with age and regional distribution. Acta Neurochir (Wien) 1990;105:30–34

    CrossRefPubMed
92. ↵
    Seung-Koo L, Dong K, Eun-Kee J, et al. Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 2003;24:741–47

    Abstract/FREE Full Text
93. ↵
    Kang KH, Kim HS, Kim SY. Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation. AJNR Am J Neuroradiol 2008;29:1487–93

    Abstract/FREE Full Text
94. ↵
    Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial—The EC/IC Bypass Study Group. N Engl J Med 1985 :313:1191–200

    CrossRefPubMedWeb of Science
95. ↵
    Nussbaum ES, Erickson DL. Extracranial-intracranial bypass for ischemic cerebrovascular disease refractory to maximal medical therapy. Neurosurgery 2000;46:37–42

    CrossRefPubMed
96. Klijn CJ, Kappelle LJ,van der Zwan A, et al. Excimer laser-assisted high-flow extracranial/intracranial bypass in patients with symptomatic carotid occlusion at high risk of recurrent cerebral ischemia: safety and long-term outcome. Stroke 2002;33:2451–58

    Abstract/FREE Full Text
97. ↵
    Amin-Hanjani S, Butler WE, Ogilvy CS, et al. Extracranial bypass in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in United States between 1992 and 2001: a population-based study. J Neurosurg 2005;103:794–804

    PubMedWeb of Science
98. ↵
    Mendelowitsch A, Taussky P, Rem JA, et al. Clinical outcome of standard extracranial-intracranial bypass surgery in patients with symptomatic atherosclerotic occlusion of the internal carotid artery. Acta Neurochir (Wien) 2004;146:95–101

    CrossRefPubMed
99. ↵
    Tummala RP, Chu RM, Nussbaum ES. Extracranial-intracranial bypass for symptomatic occlusive cerebrovascular disease not amenable to carotid endarterectomy. Neurosurg Focus 2003;14:e8

    PubMed
100. ↵
     Adams HP Jr, Powers WJ, Grubb RL Jr, et al. Preview of a new trial of extracranial-to-intracranial arterial anastomosis: the carotid occlusion surgery study. Neurosurg Clin North Am 2001;12:613–24, ix-x

     PubMed
101. ↵
     Anderson DE, McLane MP, Reichman OH, et al. Improved cerebral blood flow and CO2 reactivity after microvascular anastomosis in patients at high risk for recurrent stroke. Neurosurgery 1992;31:26–33

     PubMed
102. ↵
     Yamashita T, Kashiwagi S, Nakano S, et al. The effect of EC-IC bypass surgery on resting cerebral blood flow and cerebrovascular reserve capacity studied with stable xe-CT and acetazolamide test. Neuroradiology 1991;33:217–22

     CrossRefPubMed
103. ↵
     Schmiedek P, Piepgras A, Leinsinger G, et al. Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg 1994;81:236–44

     CrossRefPubMedWeb of Science
104. ↵
     Schaller B. Extracranial-intracranial bypass surgery to reduce the risk of haemodynamic stroke in cerebroocclusive atherosclerotic disease of the anterior cerebral circulation: a systematic review. Neurol Neurochir Pol 2007;41:457–71

     PubMed
105. ↵
     Mathis JM, Barr JD, Jungreis CA, et al. Temporary balloon test occlusion of the internal carotid artery: experience in 500 cases. AJNR Am J Neuroradiol 1995;16:749–54

     Abstract
106. ↵
     Linskey ME, Jungreis CA, Yonas H, et al. Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR Am J Neuroradiol 1994;15:829–43

     Abstract/FREE Full Text
107. ↵
     Jain R, Hoeffner EG, Deveikis JP, et al. Carotid perfusion CT with balloon occlusion and acetazolamide challenge test: feasibility. Radiology 2004;231:906–13

     CrossRefPubMedWeb of Science
108. ↵
     Okudaira Y, Arai H, Sato K. Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion: parameters reflecting cerebral perfusion pressure in the acetazolamide test. Stroke 1996;27:617–21

     Abstract/FREE Full Text
109. ↵
     Komoribayashi N, Ogasawara K, Kobayashi M, et al. Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab 2006;26:878–84. Epub 2005 Nov 9

     CrossRefPubMedWeb of Science
110. ↵
     Suga Y, Ogasawara K, Saito H, et al. Preoperative cerebral hemodynamic impairment and reactive oxygen species produced during carotid endarterectomy correlate with development of postoperative cerebral hyperperfusion. Stroke 2007;38:2712–17

     Abstract/FREE Full Text
111. ↵
     Fukuda T, Ogasawara K, Kobayashi M, et al. Prediction of cerebral hyperperfusion after carotid endarterectomy using cerebral blood volume measured by perfusion-weighted MR imaging compared with single-photon emission CT. AJNR Am J Neuroradiol 2007;28:737–42

     Abstract/FREE Full Text
112. ↵
     Hosoda K, Kawaguchi T, Shibata Y, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 2001;32:1567–73

     Abstract/FREE Full Text
113. ↵
     Ogasawara K, Yukawa H, Kobayashi M, et al. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 2003;99:504–10

     CrossRefPubMedWeb of Science